Silvercrest Asset Management’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
MCO
LG
CFM
Silvercrest Asset Management's CLPT Position: Q2 2026 in Review
Silvercrest Asset Management held its ClearPoint Neuro (CLPT) position steady in Q2 2026 at 35,700 shares worth $637K. The position accounts for ﹤0.01% of the portfolio, ranked #672.
Silvercrest Asset Management first reported a position in CLPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $778K in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.
- Silvercrest Asset Management held 35,700 shares of ClearPoint Neuro worth $637K as of Q2 2026.
- Silvercrest Asset Management left its ClearPoint Neuro share count unchanged in Q2 2026.
- ClearPoint Neuro made up ﹤0.01% of Silvercrest Asset Management's portfolio in Q2 2026, its #672 holding.
- Silvercrest Asset Management first reported a position in ClearPoint Neuro in Q1 2020 and has held it in 26 quarters since.
- Silvercrest Asset Management's ClearPoint Neuro position peaked at $778K in Q3 2025.
- 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.
Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.